Your browser doesn't support javascript.
loading
Identification and validation of a poor clinical outcome subtype of primary prostate cancer with Midkine abundance.
Zhou, Quan; Yang, Chen; Mou, Zezhong; Wu, Siqi; Dai, Xiyu; Chen, Xinan; Ou, Yuxi; Zhang, Limin; Sha, Jianjun; Jiang, Haowen.
Afiliação
  • Zhou Q; Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
  • Yang C; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
  • Mou Z; Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
  • Wu S; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
  • Dai X; National Clinical Research Center for Aging and Medicine, Fudan University, Shanghai, China.
  • Chen X; Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
  • Ou Y; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
  • Zhang L; Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
  • Sha J; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
  • Jiang H; Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Cancer Sci ; 113(11): 3698-3709, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36018546

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Linfócitos T CD8-Positivos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Linfócitos T CD8-Positivos Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article